Guangdong Guangkang Biochemical Technology Co., Ltd. (hereinafter referred to as "the Company") disclosed the "Pre-disclosure Announcement on Specific Shareholder's Share Reduction" (Announcement No.: 2026-004) on February 12, 2026, on the Giant Tide Information Network (www.cninfo.com.cn). The shareholder, Ruihong Kaiyin No. 1 Equity Investment Fund Partnership (Limited Partnership) (hereinafter referred to as "Ruihong Kaiyin No. 1"), planned to reduce its holdings of the Company’s shares by no more than 1,980,000 shares, accounting for no more than 2.6757% of the total share capital, within three months starting from three trading days after the announcement of the reduction plan (i.e., from February 25, 2026, to May 24, 2026) through centralized bidding or block trading. On February 27, 2026, the Company received a notice from the aforementioned shareholder regarding the completion of the share reduction plan. As of February 26, 2026, the share reduction plan has been completed, and the specific implementation details are announced as follows:
300804SZSE
Announcement on the Completion of Specific Shareholder's Share Reduction Plan
✨ AI Summary
Guangdong Guangkang Biochemical Technology Co., Ltd. announced the completion of a share reduction plan by its shareholder, Ruihong Kaiyin No. 1 Equity Investment Fund. The shareholder reduced a total of 1,980,000 shares, accounting for 2.6757% of the company's total share capital. The reduction was conducted through centralized bidding and block trading from February 25 to February 26, 2026.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.